Skip to content
IL

iSERA Lifesciences

534920 BSE
₹143.90 unchanged 0.00 (0.00%)
Market Cap
₹354 Cr

iSERA Lifesciences (ISERA) share price was ₹143.90 at the 28 Oct 2026 close; market capitalisation ₹354 Cr; sector Information Technology. The share price rose 1,701.0% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was under ₹1 Cr in both quarters and net profit was −₹0.34 Cr, against −₹0.02 Cr a year earlier (compared with Jun 2025). Promoters held 58.63% of iSERA Lifesciences in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 51/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹143.90 +135.91 +1,701.00% 1Y

Key Fundamentals

MicrocapIT - SoftwareInformation Technology
Market Cap
₹354 Cr
EBITDA
₹50.00 L
Return on Equity
-8.82%
Return on Capital Employed
4.21%
Debt to Equity
0.2
Book Value
₹35.07
EPS (TTM)
−₹0.07
52W High
₹151.05
52W Low
₹7.99

Price-based figures as of 28 Oct 2026, 16:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Information Technology › Computer Software & Consulting › Computers - Software & Consulting

TCS
₹2,479.4017.388,97,069 Cr7.530.96%45.59%54.93%2,88,028 Cr51,858 Cr
Infosys
₹1,138.5015.024,62,030 Cr4.902.24%31.59%38.99%1,93,466 Cr30,788 Cr
HCL Tech
₹1,407.6021.923,81,976 Cr5.023.38%22.14%27.21%1,39,354 Cr17,434 Cr
Wipro
₹189.6514.831,87,853 Cr2.381.07%15.03%18.60%1,00,632 Cr13,285 Cr
Tech Mahindra
₹1,776.2033.891,74,096 Cr5.860.83%15.98%19.82%61,022 Cr5,163 Cr
LTM
₹4,108.3023.291,21,861 Cr4.710.62%20.67%25.78%46,299 Cr5,197 Cr
Persistent Systems
₹5,880.5048.1392,765 Cr10.830.69%23.80%29.39%16,970 Cr1,922 Cr
iSERA Lifesciences (this company)
₹143.90—354 Cr4.100.00%-8.82%4.21%16 Cr-0 Cr
Median 8 companies₹1,591.9021.921,80,974 Cr4.960.90%21.41%26.50%80,827 Cr9,241 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

51 Average
Overall score

Data confidence 91/100

Category scores

Quality Poor 35
Returns, margins, earnings quality 22% weight
Valuation Poor 26
Cheap vs sector & own history 24% weight
Growth Strong 99
Sales & profit trajectory 9% weight
Financial Health Average 51
Solvency, leverage, coverage 9% weight
Momentum Strong 99
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Weaknesses

3
  • Stock is trading at 14.7 times its book value
  • Company has high debtors of 337 days.
  • Promoter holding has decreased over last 3 years: -41.4%

Technical Indicators

Oscillators

Neutral

Bearish
1
Neutral
7
Bullish
1

Overall

Neutral

Bearish
6
Neutral
7
Bullish
6

Moving Averages

Neutral

Bearish
5
Neutral
0
Bullish
5

Growth Rate

Revenue Growth
-23.51% lower than 3Y

change over 1 year

Net Income Growth
-146% lower than 3Y

change over 1 year

Cash Flow Change
49.23%

change over 1 year

EBITDA Margin Change
32.62%

change over 1 year

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0
0
0
0
0
0
0
0.19
1.16
0
Expenses
0.01
0.02
0.01
0.07
0.01
0.01
0.07
0.04
0.02
0
0.47
0.59
0.34
Operating Profit
-0.01
-0.02
-0.01
-0.07
-0.01
-0.01
-0.07
-0.04
-0.02
0
-0.28
0.57
-0.34
OPM %
—
—
—
—
—
—
—
—
—
—
-147.37%
49.14%
—
Other Income
0
0
0
0
0
0
0
0.27
0
0.01
0
0.06
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
-0.01
-0.02
-0.01
-0.07
-0.01
-0.01
-0.07
0.23
-0.02
0.01
-0.28
0.63
-0.34
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
12.7%
0%
Net Profit
-0.01
-0.02
-0.01
-0.07
-0.01
-0.01
-0.07
0.23
-0.02
0.01
-0.28
0.55
-0.34
EPS (₹)
0
0
0
-0.08
-0.01
-0.01
-0.08
0.27
-0.02
0.01
-0.33
0.65
-0.4
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
10.9
25.5
21.36
28.92
12.3
2.13
2.13
0
0
0
0.27
1.3
1.35
Expenses
10.28
25.14
20.92
28.46
11.98
2.19
0.19
0.11
0.11
0.09
0.13
1.03
1.4
Operating Profit
0.62
0.36
0.44
0.46
0.32
-0.06
1.94
-0.11
-0.11
-0.09
0.14
0.27
-0.05
OPM %
5.69%
1.41%
2.06%
1.59%
2.6%
-2.82%
91.08%
—
—
—
51.85%
20.77%
-3.7%
Other Income
0
-12.61
0
0
0
0
0
0
0
0
0
0.07
0.07
Interest
0
0.16
0.2
0.27
0.23
0.22
0.02
0
0
0
0
0
0
Depreciation
0.5
0.08
0.21
0.15
0.08
0.12
0.12
0
0
0
0
0
0
PBT
0.12
-12.49
0.03
0.04
0.01
-0.4
1.8
-0.11
-0.11
-0.09
0.14
0.34
0.02
Tax %
0%
0.4%
100%
25%
200%
5%
1.11%
0%
0%
0%
14.29%
23.53%
—
Net Profit
0.12
-12.54
0
0.04
-0.02
-0.42
1.78
-0.11
-0.11
-0.09
0.12
0.26
-0.06
EPS (₹)
0
-0.46
0
0
0
-0.02
0.06
0
0
-0.11
0.14
0.31
-0.07
Div. Payout %
0%
0%
—
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
10.6
10.6
10.6
10.6
10.6
10.6
10.6
0.3
0.3
0.32
0.32
8.41
Reserves
2.44
-10.1
-10.09
-10.05
-10.07
-10.49
-10.71
-0.31
-0.42
-0.54
-0.42
-0.16
Borrowings
4.97
6.15
6.83
7.49
7.53
6.56
2.02
0
0.13
0.18
1.61
1.66
Other Liabilities
2.54
4.61
5.57
8.19
4.12
3.81
2.59
0.02
0.04
0.1
0.05
0.65
Total Liabilities
20.55
11.26
12.91
16.23
12.18
10.48
4.5
0.01
0.05
0.06
1.56
10.56
Fixed Assets
6.65
0.48
0.44
0.45
0.75
0.62
0.43
0
0
0
0
0
CWIP
1.96
0
0
0
0
0
0
0
0
0
0
0
Investments
4.2
0
0
0
0
0
0
0
0
0
0
0
Other Assets
7.74
10.78
12.47
15.78
11.43
9.86
4.07
0.01
0.05
0.06
1.56
10.56
Total Assets
20.55
11.26
12.91
16.23
12.18
10.48
4.5
0.01
0.05
0.06
1.56
10.56
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.5
0.81
-0.63
-0.51
0.34
0.97
4.45
-0.3
-0.12
-0.06
-1.4
-5.35
Investing
-1.16
-0.4
-0.16
-0.16
-0.38
0
0.1
0
0
0
0
0.06
Financing
0.69
-0.42
0.77
0.66
0.04
-0.97
-4.55
0.3
0.13
0.06
1.42
8.14
Net Cash Flow
0.04
-0.01
-0.02
-0.01
0
0
-0.01
0
0
0
0.02
2.85
Free Cash Flow
-0.78
0.41
-0.79
-0.67
-0.04
0.97
4.55
-0.3
-0.12
-0.06
-1.4
-5.35
CFO/OP
81
225
-143
-109
112
-1,650
229
273
109
67
-986
-1,952
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
193
123
175
178
297
1,470
499
—
—
—
419
337
Inventory Days
—
—
0
0
0
0
—
—
—
—
—
—
Cash Conversion Cycle
193
123
175
178
297
1,470
499
—
—
—
419
337
Working Capital Days
174
65.13
91.59
73.58
170
1,042
260
—
—
—
351
225
ROCE %
0.68%
2.27%
3.29%
4.03%
2.98%
-2.44%
42.42%
-11.58%
—
—
19.05%
5.95%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view iSERA Lifesciences insights

54 extracted metrics + investor summaries across FY08–FY27.

Shareholding Pattern

FIIs0.02%Promot.58.63%Others9.78%Public31.57%As ofSep 2026

Documents

Frequently Asked Questions about iSERA Lifesciences

What does iSERA Lifesciences Ltd do?
Incorporated in 1993, Covidh Technologies Ltd is engaged in IT/ITES business.[1]
Where is iSERA Lifesciences Ltd (ISERA) listed?
iSERA Lifesciences Ltd trades under code 534920 on the BSE.
Which sector does iSERA Lifesciences Ltd belong to?
iSERA Lifesciences Ltd is classified under the Information Technology sector, in the Computer Software & Consulting industry.
What is the market capitalisation of iSERA Lifesciences Ltd?
iSERA Lifesciences Ltd has a market capitalisation of ₹353.9 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of iSERA Lifesciences Ltd?
Over the last 52 weeks iSERA Lifesciences Ltd has traded between ₹7.99 and ₹151.05 as of 28 Oct 2026.
What is the Return on Equity (ROE) of iSERA Lifesciences Ltd?
iSERA Lifesciences Ltd reported a return on equity of -8.82%. Its debt-to-equity ratio is 0.20.

Company Information

Incorporated in 1993, Covidh Technologies Ltd is engaged in IT/ITES business.[1]

Website covidh.co.in
Face Value ₹ 10
Shares Outstanding 2,45,93,468

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/534920.md for iSERA Lifesciences Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More IT Software stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month